My Account Log in

2 options

Anti-obesity drug discovery and development. Volume 4 / edited by Atta-ur-Rehman.

EBSCOhost Academic eBook Collection (North America) Available online

View online

Ebook Central College Complete Available online

View online
Format:
Book
Author/Creator:
Rahman, Atta-ur, Author.
Contributor:
Rahman, Atta-ur-, 1942- editor.
Series:
Anti-Obesity Drug Discovery and Development ; 4
Language:
English
Subjects (All):
Appetite depressants.
Physical Description:
1 online resource (245 pages)
Edition:
1st ed.
Place of Publication:
Sharjah, United Arab Emirates : Bentham Science Publishers, 2018.
Summary:
Obesity is a complex health problem, caused by a number of factors such as excessive food intake, lack of physical activity, genetic predisposition, endocrine disorders, medications and psychiatric illnesses. The incidence of obesity among populations in both the developing and the developed world has reached epidemic proportions. In response to this, efforts to control and treat obesity have also been vigorously pursued, ranging from activities focused on raising awareness about lifestyle changes to the discovery and development of safe and effective anti-obesity drugs. Anti-obesity Drug Discovery and Development is a book series focused on this very important area of healthcare research. Each volume presents insightful updates on pharmaceutical research and development for clinical researchers and healthcare professionals involved in obesity treatment programs. The fourth volume of this series is a compilation of 6 reviews on anti-obesity treatment strategies including updates on obesity and cancer prevention through dietary modulation, the role of anti-obesity medications in polycystic ovary syndrome, potential anti-obesity strategies targeting mitochondria, calcium silicate based formulations for anti-obesity therapy, and the identification of obesity medications from natural products and plants.
Contents:
Cover
Title
Biblography
End User License Agreement
Contents
Preface
List of Contributors
Dietary Modulation, Obesity and Cancer Prevention
Jennifer Man Fan Wan1,* and Hiu Yee Kwan2
INTRODUCTION
HOW DIET RELATES TO CANCERS?
Dietary Factors that Promote the Cancer Initiation
Ingestion of Powerful, Direct-Acting Carcinogens or their Precursors
Ingestion of Carcinogens that are Produced via Food Processing
Ingestion of Carcinogens Produced in Stored Food
Formation of Carcinogens in the Body
DIETARY FACTORS THAT PROMOTE THE CANCER DEVELOPMENT
GENERAL MECHANISM OF HOW OBESITY CAN CAUSE AND PROMOTE CANCER
DIETARY COMPONENTS WITH CANCER PREVENTION POTENTIAL
DIETARY COMPONENTS THAT AFFECT BODY WEIGHT
PROSPECTIVE FOR THE ANTI-CANCER STUDY
SUMMARY
ABBREVIATIONS
CONSENT FOR PUBLICATION
CONFLICT OF INTEREST
ACKNOWLEDGEMENTS
REFERENCES
The Role of Anti-Obesity Medications in Polycystic Ovary Syndrome
Ilgın Turkcuoglu1,* and Rauf Melekoglu2
Orlistat, Sibutramine, and Rimonabant
Insulin-sensitizing Drugs (Metformin, Rosiglitazone, Pioglitazone, and D-chiro-inositol)
GLP-1 Agonists (Exenatide, Liraglutide), Phentermine and Topiramate
Other Drugs
Sirtuins and Bile Acids: Potential Anti-obesity Strategies Targeting Mitochondria
João Alves Amorim1,#, João Soeiro Teodoro1,2,#, Carlos Marques Palmeira1,2 and Anabela Pinto Rolo1,2,*
SIRTUIN ACTIVATORS AS A NOVEL ANTI-OBESITY STRATEGY
Sirtuins
Physiological Role of Sirtuins in Metabolism
Physiological Role of Sirtuins and Obesity and Metabolic Syndrome
Sirtuins Activators for Therapy
Sirtuin Activators for Therapy in Obesity
NAD+-boosting Compounds.
BILE ACIDS, OBESITY AND MITOCHONDRIA
Bile Acid Receptors Discovery and Properties
BA Effects and Mitochondria
CONCLUDING REMARKS
Development and Characterization of Calcium Silicate Based Formulations for Anti-Obesity Therapy: Orlistat
Sunil K. Jain*
FLOATING MICROSPHERES
Preparation of OT Absorbed CS
Preparation of Floating Microspheres
Characterization of Floating Microspheres
Micromeritic Properties and Morphology
Percentage Buoyancy and Drug Entrapment
In vivo Drug Release of Floating Microspheres
Gamma Scintigraphy
Pharmacokinetic Studies
FLOATING GRANULES
Preparation of Floating Granules
Characterization of Floating Granules
Drug Content and Floating Ability
In vitro Drug Release of Floating Granules
CONCLUSION
Multi Targeted Strategies Towards Identification of Potential Drug Candidates from Natural Products in the Management of Obesity
Baddireddi Subhadra Lakshmi*, 1,2 and Gopal Thiyagarajan2
CURRENT TREATMENT STRATEGIES FOR OBESITY
MEDICINAL PLANTS AS A SOURCE FOR NOVEL DRUGS
MECHANISM AND MOLECULAR TARGETS OF OBESITY
INHIBITION OF LIPID ABSORPTION
Pancreatic Lipase Inhibitors
SUPPRESSION OF APPETITE
Glucagon Like Peptide 1 Analogues and Dipeptidyl Peptidase 4 Inhibitors
Cholecystokinin Agonists
Neuropeptide Y Antagonist
Leptin
Protein Tyrosine Phosphatase 1B Inhibitors
INHIBITION OF ADIPOGENESIS
Peroxisome Proliferator Activated Receptor γ (PPARγ)
Adiponectin
Partial PPARγ Agonists
ENERGY EXPENDITURE
Thermogenesis
MODULATION OF LIPID METABOLISM
Lipolysis
β-Oxidation
Adenosine Monophosphate (AMP) Kinase Activators.
Sirtuin 1 as a Novel Target of Obesity
MULTIFUNCTIONAL ROLE OF NATURAL ANTIOBESITY COMPOUNDS
CLINICAL TRIALS STUDY
Anti-Obesity Molecules from Plants and their Mode of Action
Megha Valsaraj, Navaneetha Saseendran, Arun Subash Koorapally and Anu Augustine*
GENERAL INTRODUCTION
Obesity
Definition and Assessment of Obesity
Genetic and Environmental Factors Causing Obesity
Endocrine and Metabolic Factors
Psychological Factors
Control of Appetite and Energy Expenditure
Obesity Management
Role of Medicinal Plants in Obesity Treatment
Mechanism of Action of Anti obesity Agents from Plants
Modifying Serum Lipoprotein
Modifying Serum Apolipoproteins
Enzyme Inhibition
Inhibitors of Adipogenesis and Adipogenic Factors
Blocking Intestinal Absorption
Appetite Suppressants
Details of Plants Selected for Study
Holoptelea Integrifolia
Averrhoa bilimbi Linn.
Terminalia chebula Retz.
Acorus calamus Linn.
Picrorhiza kurroa Royle ex Benth
Experimental Model and Findings
Methodology
Animals
Acute Oral Toxicity
Establishment of Experimental Model
Drug Treatment
Effect of Plant Extracts on Serum Lipids
Effect of Plant Extracts on HDL Cholesterol Levels
Effect of Plant Extracts on LDL Cholesterol Levels
Effect of Plant Extracts on Apolipoproteins
Effect of Different Plant Extracts on Enzymes Involved in Cholesterol Pathway
HMG-CoA Reductase
Lecithin-Cholesterol Acyltransferase
Lipoprotein Lipase
Effect of Different Plant Extracts on Intestinal Fat Absorption
Effect of Different Plant Extracts on Inhibition of Adipogenesis and Adipogenic Factors
REFERENCES.
Subject Index
Back Cover.
Notes:
Description based on print version record.
ISBN:
9781681085586
1681085585
OCLC:
1159421134

The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.

Find

Home Release notes

My Account

Shelf Request an item Bookmarks Fines and fees Settings

Guides

Using the Find catalog Using Articles+ Using your account